Vivos Therapeutics, Inc. (VVOS)
NASDAQ: VVOS · Real-Time Price · USD
2.030
0.00 (0.00%)
Dec 31, 2025, 4:00 PM EST - Market closed
Vivos Therapeutics Analyst Ratings
Total Analysts
2
Consensus Rating
Strong Buy
Price Target
$6.25
Upside
+207.88%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Ascendiant Capital | Ascendiant Capital | Strong Buy Maintains $6.5 → $5.5 | Strong Buy | Maintains | $6.5 → $5.5 | +170.94% | Dec 3, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Initiates $7 | Strong Buy | Initiates | $7 | +244.83% | Nov 17, 2025 |
| Ascendiant Capital | Ascendiant Capital | Strong Buy Maintains $6.2 → $6.5 | Strong Buy | Maintains | $6.2 → $6.5 | +220.20% | Sep 9, 2025 |
| Ascendiant Capital | Ascendiant Capital | Strong Buy Maintains $6.6 → $6.2 | Strong Buy | Maintains | $6.6 → $6.2 | +205.42% | Apr 15, 2025 |
| Ascendiant Capital | Ascendiant Capital | Strong Buy Reiterates $6.6 | Strong Buy | Reiterates | $6.6 | +225.12% | Nov 20, 2024 |
| Alliance Global Partners | Alliance Global Partners | Strong Buy Maintains $8.25 → $6 | Strong Buy | Maintains | $8.25 → $6 | +195.57% | Nov 19, 2024 |
| Ascendiant Capital | Ascendiant Capital | Strong Buy Maintains $6.4 → $6.6 | Strong Buy | Maintains | $6.4 → $6.6 | +225.12% | Aug 20, 2024 |
| Ascendiant Capital | Ascendiant Capital | Strong Buy Initiates $63 | Strong Buy | Initiates | $63 | +2,978.82% | Jan 17, 2023 |
| Roth Capital | Roth Capital | Strong Buy Maintains $275 → $250 | Strong Buy | Maintains | $275 → $250 | +12,215.27% | Aug 13, 2021 |
| Roth Capital | Roth Capital | Strong Buy Maintains $300 → $275 | Strong Buy | Maintains | $300 → $275 | +13,446.80% | May 18, 2021 |
| Craig-Hallum | Craig-Hallum | Strong Buy Initiates $300 | Strong Buy | Initiates | $300 | +14,678.33% | Jan 11, 2021 |
| Roth Capital | Roth Capital | Strong Buy Initiates $300 | Strong Buy | Initiates | $300 | +14,678.33% | Jan 5, 2021 |